Non-myeloablative umbilical cord blood transplantation for atypical dyskeratosis congenita.

Amber GibsonDristhi RagoonananPriti TewariDemetrios PetropoulosNidra RodriguezCourtney DiNardoKris M MahadeoSajad Jawad Khazal

Published in: Pediatric transplantation (2021)

In this case of atypical DC with a previously unreported germline missense mutation in PMS2, the patient was successfully treated with an umbilical cord blood transplant with a non-myeloablative regimen.

Keyphrases

umbilical cord
mesenchymal stem cells
stem cell transplantation
allogeneic hematopoietic stem cell transplantation
cell therapy
dendritic cells
case report
bone marrow
intellectual disability
dna repair
high dose
stem cells
acute myeloid leukemia
autism spectrum disorder
oxidative stress